Invited Letters

1. Hurt MA.  Dermatopathology standards.  J Cutan Pathol 1996; 23(2):196.

2. Hurt MA.  Critical Commentary to Apocrine Carcinoma with signet ring cells and histiocytoid features.  A potentially confusing axillary tumor.  Pathol Res Pract 1997; 193:721-722.

3. Hurt MA.  Whither Dermatopathology? (Reply)  J Cutan Pathol 1999; 26(8):412-413.

4. Hurt MA.  Medical-Legal.  Should a pathologist make recommendations to a clinician about management of a patient or should a pathologist make diagnoses only—and no more?  If a pathologist does advise therapy, should it be in the form of a "recommendation" or an unambiguous statement, such as "The neoplasm should be removed in its entirety with a narrow margin?  When a pathologist makes a recommendation about management to a clinician, does that mandate a clinician to follow the recommendation?  Dermatopathol Pract Concept 2002; 8(3):Article 10.

5. Hurt MA.  Medical-Legal.  Dermatopathol Pract Concept 2003; 9(1):internet @

6. Hurt MA.  Medical-Legal.  Dermatopathol Pract Concept 2003; 9(2):internet @

7. Hurt MA.  Response to question To colleagues.  Censorship in medical publishing.  Dermatopathol Pract Concept 2004; 10(3):article 17.

8. Hurt MA.  Follow-Up On Censorship In Medical Publishing.  Dermatopathol Pract Concept 2004; 10(4):article 22.

9. Hurt MA.  Response to the question to colleagues:  Is "in-house review" of articles with a rejection rate of 50 % of all submissions compatible with a journal being called "peer-reviewed"?  Dermatopathol Pract Concept 2006; 12(1):article 13.

10. Hurt MA.  Response to the question to colleagues:  Do you use the word “dysplasia”?  Dermatopathol Pract Concept 2007; 13(2):article 3.

11. Hurt MA.  Response to the question to colleagues:  Should skin biopsies come together with clinical photographs?  Dermatopathol Pract Concept 2007; 13(4):article 17.

12.  Hurt MA. Response to Question to Colleagues: Do you count mitotic figures in melanomas measuring 1 mm or less in thickness? Dermatopathol Pract Concept 2010; 16(3):article 5.